Matthew Winter

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Nicholas C. Turner, Belinda Kingston, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 334 citations · Full text

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Annals of Oncology · 2022 · 173 citations · Full text

68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology

Israel Berger, Chandra Annabattula, Jannet F. Lewis et al. · Prostate Cancer and Prostatic Diseases · 2018 · 129 citations

Urology, Tumoral Pathology, Oncologic Imaging +8

Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease

Christianne Lok, Nienke E. van Trommel, Leon Massuger et al. · European Journal of Cancer · 2020 · 104 citations · Full text

Gestational Trophoblastic Disease, Gynecology, Maternal Health +7